Diffuse large B-cell lymphoma trials in New Zealand

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  Where

  Auckland

  Age

  18 years and over

  People

  290 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT05139017 · EU 2022-502646-27-00
• Phase 2Taking people
  A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

  Where

  Auckland, Christchurch, Newtown

  Age

  18 years to 75 years

  People

  60

  Run by

  Malaghan Institute of Medical Research

  See details and how to joinNCT06486051
• Phase 3Taking people
  A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

  Where

  Grafton, Wellington

  Age

  75 years and over

  People

  300 worldwide

  Run by

  Nordic Lymphoma Group

  See details and how to joinNCT04332822 · EU 2022-502887-19-00
• Phase 2Taking people
  DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  Where

  Auckland, Palmerston North

  Age

  18 years and over

  People

  102 worldwide

  Run by

  ImmunoVaccine Technologies, Inc. (IMV Inc.)

  See details and how to joinNCT04920617